XML 58 R32.htm IDEA: XBRL DOCUMENT v3.22.1
Financial instruments by category
12 Months Ended
Dec. 31, 2021
Financial Instruments [Abstract]  
Disclosure of financial instruments [text block]

Note 25     Financial instruments by category

Assets as per statement

of financial position

Amounts in US$ '000

2021

2020

Financial assets at fair value through profit or loss

Derivative financial instrument assets

126

1,013

Cash and cash equivalents

427

823

553

1,836

Other financial assets at amortized cost

  

  

Trade receivables

70,531

46,918

To be recovered from co-venturers (Note 34)

4,680

2,236

Other financial assets (a)

14,747

13,392

Cash and cash equivalents

100,177

201,084

190,135

263,630

Total financial assets

190,688

265,466

(a)Non-current other financial assets relate to contributions made for environmental obligations according to Brazilian government regulations. Current other financial assets correspond to short-term investments with original maturities up to twelve months and over three months.

Liabilities as per statement

of financial position

Amounts in US$ ‘000

2021

2020

Liabilities at fair value through profit and loss

  

  

Derivative financial instrument liabilities

20,757

15,094

20,757

15,094

Other financial liabilities at amortized cost

  

  

Trade payables

86,672

63,528

Payables to LGI (former non-controlling interest)

3,528

To be paid to co-venturers (Note 34)

953

5,760

Lease liabilities

20,744

22,347

Borrowings

674,092

784,586

782,461

879,749

Total financial liabilities

803,218

894,843

25.1 Credit quality of financial assets

The credit quality of financial assets that are neither past due nor impaired can be assessed by reference to external credit ratings (if available) or to historical information about counterparty default rates:

Amounts in US$ ‘000

2021

2020

Trade receivables

  

  

Counterparties with an external credit rating (Moody’s, S&P, Fitch)

  

  

Aa2

7,132

2,321

Baa3

24,163

26,252

Ba2

3,847

Ba1

4,984

1,333

B3

32

B

70

Counterparties without an external credit rating

Group 1 (a)

34,182

13,133

Total trade receivables

70,531

46,918

(a)Group 1 – existing customers (more than 6 months) with no defaults in the past.

All trade receivables are denominated in US Dollars, except in Brazil where they are denominated in Brazilian Real.

Cash at bank and other financial assets (a)

Amounts in US$ ‘000

2021

2020

Counterparties with an external credit rating (Moody’s, S&P, Fitch, BRC Investor Services)

  

  

A2

53,114

122,229

A3

27,257

44,808

AAA

3,529

18,119

Ba1

67

2,343

Baa1

1,605

574

Baa2

3,708

2,146

Ba3

5,117

43

Aa2

1,073

Ba2

21

Aa3

8

Counterparties without an external credit rating

20,908

23,941

Total

115,334

215,276

(a)The remaining balance sheet item ‘cash and cash equivalents’ corresponds to cash on hand amounting to US$ 17,000 (US$ 23,000 in 2020).

25.2 Financial liabilities- contractual undiscounted cash flows

The table below analyses the Group’s financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet to the contractual maturity date. The amounts disclosed in the table are the contractual undiscounted cash flows.

Less than 1

Between 1

Between 2

Over 5

Amounts in US$ ‘000

year

and 2 years

and 5 years

years

As of December 31, 2021

Borrowings

40,943

38,550

263,550

513,750

Lease liabilities

9,230

6,558

5,820

2,871

Trade payables

85,132

1,540

To be paid to co-venturers (Note 34)

953

136,258

46,648

269,370

516,621

As of December 31, 2020

  

  

  

  

Borrowings

48,311

49,444

538,000

378,875

Lease liabilities

10,890

6,230

5,294

3,653

Trade payables

62,408

1,120

To be paid to co-venturers (Note 34)

1,994

3,766

Payables to LGI

3,528

127,131

60,560

543,294

382,528

25.3 Fair value measurement of financial instruments

Accounting policies for financial instruments have been applied to classify as either: amortized cost, financial assets at fair value through profit or loss and fair value through other comprehensive income. For financial instruments that are measured in the statement of financial position at fair value, IFRS 13 requires a disclosure of fair value measurements by level according to the following fair value measurement hierarchy:

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices).

Level 3 - Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs).

This note provides an update on the judgements and estimates made by the Group in determining the fair values of the financial instruments since the last annual financial report.

25.3.1 Fair value hierarchy

The following table presents the Group’s financial assets and financial liabilities measured and recognized at fair value as of December 31, 2021 and 2020 on a recurring basis:

As of December 31,

Amounts in US$ ‘000

Level 1

Level 2

2021

Assets

  

  

  

Cash and cash equivalents

  

  

  

Money market funds

427

427

Derivative financial instrument assets

  

  

  

Commodity risk management contracts

126

126

Total Assets

427

126

553

Liabilities

Derivative financial instrument liabilities

Commodity risk management contracts

20,757

20,757

Total Liabilities

20,757

20,757

As of December 31,

Amounts in US$ ‘000

Level 1

Level 2

2020

Assets

  

  

  

Cash and cash equivalents

  

  

  

Money market funds

823

823

Derivative financial instrument assets

  

  

  

Commodity risk management contracts

1,013

1,013

Total Assets

823

1,013

1,836

Liabilities

Derivative financial instrument liabilities

Commodity risk management contracts

15,094

15,094

Total Liabilities

15,094

15,094

There were no transfers between Level 2 and 3 during the period.

The Group did not measure any financial assets or financial liabilities at fair value on a non-recurring basis as of December 31, 2021.

25.3.2 Valuation techniques used to determine fair values

Specific valuation techniques used to value financial instruments include:

The use of quoted market prices or dealer quotes for similar instruments.
The mark-to-market fair value of the Group’s outstanding derivative instruments is based on independently provided market rates and determined using standard valuation techniques, including the impact of counterparty credit risk and are within level 2 of the fair value hierarchy.
The fair value of the remaining financial instruments is determined using discounted cash flow analysis. All of the resulting fair value estimates are included in level 2.

25.3.3 Fair values of other financial instruments (unrecognized)

The Group also has a number of financial instruments which are not measured at fair value in the balance sheet. For the majority of these instruments, the fair values are not materially different to their carrying amounts, since the interest receivable/payable is either close to current market rates or the instruments are short-term in nature.

Borrowings are comprised primarily of fixed rate debt and variable rate debt with a short-term portion where interest has already been fixed. They are classified under other financial liabilities and measured at their amortized cost.

The fair value of these financial instruments as of December 31, 2021 amounts to US$ 661,404,000 (US$ 797,126,000 in 2020). The fair values are based on market price for the Notes and cash flows discounted for other borrowings using a rate based on the borrowing rate and are within level 1 and level 2 of the fair value hierarchy, respectively.